Floatz logo

Lidocaine

Fibromyalgia

Peking University Third HospitalSmall moleculePhase 2Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Fibromyalgia cohort.

Asset / SponsorPhaseRating
Duloxetine
Cukurova University
Phase 4BBB
Pregabalin
Yung Shin Pharm. Ind. Co., Ltd.
Phase 4BB
PIPERAZINE, 1-(BIS(4-FLUOROPHENYL)METHYL)-4-(3-PHENYL-2-PROPENYL)-, (E)-
Taipei Veterans General Hospital, Taiwan
Phase 4BB
Zonisamide
University of Pittsburgh
Phase 4B
Gabapentin
Good Samaritan Regional Medical Center, Oregon
Phase 3B

View all 33 →

Same molecule, other indications

Lidocaine is also rated in:

peripheral neuropathyActive
BBB
Indicative · Phase 4
79 / 100
View asset →
postherpetic neuralgiaDormant
BBB
Indicative · Phase 4
78 / 100
View asset →
post-operative pain, non-human animalActive
BBB
Indicative · Phase 4
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →